Kras Weronika, Carletta Andrea, Montis Riccardo, Sullivan Rachel A, Cruz-Cabeza Aurora J
Department of Chemical Engineering and Analytical Science, The University of Manchester, Manchester, UK.
Chemical Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, UK.
Commun Chem. 2021 Mar 17;4(1):38. doi: 10.1038/s42004-021-00473-7.
Almost 200 years ago, benzamide was reported as polymorphic with two of its forms (II and III) found to be difficult to crystallise. In a recent study, it was shown that benzamide form I can easily convert into benzamide form III using mechanochemistry in the presence of nicotinamide. Here we show, experimentally and computationally, that this transformation is the result of a thermodynamic switch between these two polymorphic forms driven by the formation of solid solutions with small amounts of nicotinamide. The presence of nicotinamide in the crystallisation environment promotes the robust and exclusive crystallisation of the elusive form III. These results represent a promising route to the synthesis and utilisation of elusive polymorphs of pharmaceutical interest.
大约200年前,苯甲酰胺被报道具有多晶型现象,其两种晶型(II和III)难以结晶。在最近的一项研究中,结果表明,在烟酰胺存在的情况下,利用机械化学方法,苯甲酰胺晶型I可以很容易地转化为苯甲酰胺晶型III。在此,我们通过实验和计算表明,这种转变是由与少量烟酰胺形成固溶体驱动的这两种多晶型之间热力学转换的结果。结晶环境中烟酰胺的存在促进了难以捉摸的晶型III的稳健且排他性结晶。这些结果为具有药学意义的难以捉摸的多晶型物的合成和利用提供了一条有前景的途径。